Avandia Safety Being Reconsidered By FDA Panel
Despite GlaxoSmithKline saying it does not plan to make almost-discontinued diabetes drug Avandia available in the USA, the FDA’s Endocrinologic
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓